ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,642
Diagnostic referrals
1,067
Outstanding pathways
342

Screening pathway

  1. Screening5,642Encounters
  2. Positive finding1,998Documented findings
  3. Referral1,067Diagnostic referrals
  4. Follow-up1,284Diagnostic visits
  5. Outcome725Resolved pathways

Stage totals use different units. Pending pathways: 285. Insufficient observation: 57.

Participant insight

Expanded synthetic participant 0301 · EXP-0301Synthetic · Site D

Full participant history through 2027-11-07, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-07-05
  4. · Diagnostic referral · EXP-0301-T-R
  5. · Contact attempt · Unsuccessful
  6. · Barrier documented · Appointment coordination
  7. · Diagnostic booking · Initial booking
  8. · Contact attempt · Reached
  9. · Barrier documented · Transport difficulty
  10. · Navigation intervention · Coordination support
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · High-grade lesion
  14. · Follow-up disposition · Resolved · EXP-0301-T-R
  15. · Treatment · Synthetic precancer treatment
  16. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2026-04-04
  17. · Screening · HPV DNA · Repeat · Prior VIA positive
  18. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0371 · Expanded synthetic participant 0371Site E — Resource-Constrained Navigation Programme
EXP-0372 · Expanded synthetic participant 0372Site E — Resource-Constrained Navigation Programme
EXP-0374 · Expanded synthetic participant 0374Site C — Rural Outreach Programme
EXP-0375 · Expanded synthetic participant 0375Site C — Rural Outreach Programme
EXP-0376 · Expanded synthetic participant 0376Site D — Community Engagement Programme
EXP-0377 · Expanded synthetic participant 0377Site D — Community Engagement Programme
EXP-0378 · Expanded synthetic participant 0378Site E — Resource-Constrained Navigation Programme
EXP-0379 · Expanded synthetic participant 0379Site E — Resource-Constrained Navigation Programme
EXP-0380 · Expanded synthetic participant 0380Site B — Peri-Urban Access Programme
EXP-0381 · Expanded synthetic participant 0381Site C — Rural Outreach Programme
EXP-0382 · Expanded synthetic participant 0382Site D — Community Engagement Programme
EXP-0383 · Expanded synthetic participant 0383Site C — Rural Outreach Programme
EXP-0385 · Expanded synthetic participant 0385Site A — Urban Referral Hub
EXP-0386 · Expanded synthetic participant 0386Site B — Peri-Urban Access Programme
EXP-0387 · Expanded synthetic participant 0387Site D — Community Engagement Programme
EXP-0388 · Expanded synthetic participant 0388Site D — Community Engagement Programme
EXP-0389 · Expanded synthetic participant 0389Site A — Urban Referral Hub
EXP-0390 · Expanded synthetic participant 0390Site E — Resource-Constrained Navigation Programme
EXP-0391 · Expanded synthetic participant 0391Site C — Rural Outreach Programme
EXP-0392 · Expanded synthetic participant 0392Site C — Rural Outreach Programme
EXP-0393 · Expanded synthetic participant 0393Site D — Community Engagement Programme
EXP-0394 · Expanded synthetic participant 0394Site D — Community Engagement Programme
EXP-0396 · Expanded synthetic participant 0396Site A — Urban Referral Hub
EXP-0397 · Expanded synthetic participant 0397Site D — Community Engagement Programme
EXP-0399 · Expanded synthetic participant 0399Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1970
HPV DNA
2945
Cytology
727

Navigation activity

Barrier documented
937
Contact attempt
1505
Navigation intervention
417
Diagnostic booking
1301
Diagnostic visit
1284

Documented barriers

Contact difficulty
298
Transport difficulty
311
Appointment coordination
328

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.